There are currently over 20 clinical trials underway searching for a COVID-19 vaccine. Dr. Nancy Nielsen, Senior Associate Dean for Health Policy at UB's Jacobs School of Medicine and Biomedical Sciences, has been following the progress of these efforts. She's been recently intrigued by the "Oxford vaccine," which is being studied in the United Kingdom. "This has been peer-reviewed," said Nielsen, who explained "it uses a genetically-modified adenovirus" to produce neutralizing antibodies. The British effort is funded in part by money from the U.S. federal government "with the promises that we will be able to get vaccine doses if they are effective. "
Monday - Friday, 6 a.m. - 10 a.m.
Jay joined Buffalo Toronto Public Media in 2008 and has been the local host for NPR's "Morning Edition" ever since. In June 2022, he was named one of the co-hosts of BTPM's "What's Next."
A graduate of St. Mary's of the Lake School, St. Francis High School, and Buffalo State College, Jay has worked most of his professional career in Buffalo. Outside of public media, he continues in longstanding roles as the public address announcer for the Buffalo Sabres of the National Hockey League and as play-by-play voice of Canisius College basketball.
Jay joined Buffalo Toronto Public Media in 2008 and has been the local host for NPR's "Morning Edition" ever since. In June 2022, he was named one of the co-hosts of BTPM's "What's Next."
A graduate of St. Mary's of the Lake School, St. Francis High School, and Buffalo State College, Jay has worked most of his professional career in Buffalo. Outside of public media, he continues in longstanding roles as the public address announcer for the Buffalo Sabres of the National Hockey League and as play-by-play voice of Canisius College basketball.